SCHEMBL9524640

SCHEMBL9524640

Cn1nnc2ccc(Cc3ccccc3-n3ccnc3)cc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC9A1 P19634 1/20 0.38
KEAP1 Q14145 1/20 0.38
IDO1 P14902 1/20 0.38
NOTUM Q6P988 1/20 0.36
HTR5A P47898 1/20 0.36
FGFR1 P11362 1/20 0.36
CYP3A4 P08684 5/20 0.36
CYP1A2 P05177 4/20 0.36
CYP2D6 P10635 4/20 0.36
CYP2C19 P33261 4/20 0.36
CYP2C9 P11712 3/20 0.36
ALDH1A1 P00352 3/20 0.36
LMNA P02545 2/20 0.36
MAPT P10636 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
MEN1 O00255 1/20 0.36
MAPK1 P28482 1/20 0.36
PMP22 Q01453 1/20 0.36
KMT2A Q03164 1/20 0.36
CYP19A1 P11511 5/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3279244 0.86 IDO1 (0.41) IDO1HTR5AFGFR1CYP3A4CYP1A2
Nitric Acid SCHEMBL9527186 0.84 NSD2 (0.39) IDO1ALDH1A1LMNAMAPTMEN1
SCHEMBL3279905 0.80 CTNNB1 (0.46) IDO1HTR5AFGFR1CYP3A4CYP1A2
SCHEMBL9869542 0.79 SLC9A1 (0.47) SLC9A1IDO1HTR5AFGFR1
SCHEMBL9868401 0.79 NOTUM (0.38) SLC9A1KEAP1NOTUMALDH1A1MAPT
SCHEMBL9196161 0.78 IDO1 (0.43) IDO1HTR5AFGFR1CYP3A4CYP1A2
SCHEMBL7463718 0.78 NPC1 (0.44) IDO1NOTUMHTR5AFGFR1CYP3A4
SCHEMBL9664168 0.78 HTR5A (0.41) IDO1HTR5AFGFR1CYP3A4CYP1A2
SCHEMBL9868540 0.78 TSHR (0.38) IDO1HTR5AFGFR1CYP3A4CYP1A2
SCHEMBL9526934 0.78 FGFR1 (0.35) IDO1HTR5AFGFR1CYP3A4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0293978-B1 (1H-AZOL-1-YLMETHYL)SUBSTITUTED BENZOTRIAZOLE DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 1993-09-15 EP claimed
WO-1992018132-A1 PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA COMTAINING A 5 ALPHA-REDUCTASE INHIBITOR MERCK & CO., INC. (US) 1992-10-29 WO claimed
US-4943574-A AROMATASE INHIBITORS, ESTROGEN DISORDERS JANSSEN PHARMACEUTICA N.V. (BE) 1990-07-24 US claimed
EP-0293978-A2 (1H-azol-1-ylmethyl)substituted benzotriazole derivatives JANSSEN PHARMACEUTICA N.V. (BE) 1988-12-07 EP claimed
EP-0293978-B1 (1H-AZOL-1-YLMETHYL)SUBSTITUTED BENZOTRIAZOLE DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 1993-09-15 EP disclosed
US-5039677-A Estrogen inhibitor JANSSEN PHARMACEUTICA N.V. (CA) 1991-08-13 US disclosed
US-4943574-A AROMATASE INHIBITORS, ESTROGEN DISORDERS JANSSEN PHARMACEUTICA N.V. (BE) 1990-07-24 US disclosed